Filter
1183
Filtered Results: 1183
Text search:
Cochrane
Featured
Recommendations
134
New Publications
178
Language
Document type
No document type
563
Guidelines
273
Studies & Reports
202
Manuals
56
Fact sheets
37
Training Material
26
Strategic & Response Plan
13
Resource Platforms
9
Situation Updates
3
Infographics
1
Countries / Regions
Global
43
India
38
Latin America and the Carribbean
28
Western and Central Europe
27
Russia
25
South Africa
24
Colombia
15
Africa
15
Brazil
14
Ukraine
14
Eastern Europe
14
Germany
13
Mozambique
13
Argentina
11
Indonesia
10
Ethiopia
9
Kenya
9
Peru
9
Angola
8
Liberia
7
Malawi
7
Guinea-Bissau
6
Nepal
6
Syria
6
Middle East and North Africa
6
Asia
6
Uganda
5
Philippines
5
Ecuador
5
Yemen
5
East and Southern Africa
5
South–East Asia Region
5
Eastern Europe and Central Asia
5
Spain
5
Burkina Faso
4
Sierra Leone
4
Nigeria
4
Cameroon
4
Rwanda
4
Bangladesh
4
Bolivia
4
West and Central Africa
4
Paraguay
4
Zimbabwe
3
Haiti
3
South Sudan
3
Tanzania
3
Benin
3
Myanmar / Burma
3
Estonia
3
Kyrgyzstan
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
Mali
2
Ghana
2
Zambia
2
Thailand
2
Sudan
2
Namibia
2
Botswana
2
El Salvador
2
Mexico
2
Chile
2
Venezuela
2
Southern Africa
2
Canada
2
Tajikistan
2
Moldova
2
North America
2
France
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Niger
1
Somalia
1
Jordan
1
Afghanistan
1
Lebanon
1
Malaysia
1
Ireland
1
Singapore
1
Dominican Republic
1
Cuba
1
Honduras
1
Guatemala
1
Madagascar
1
Lesotho
1
Nicaragua
1
Congo-Brazzaville
1
Qatar
1
Romania
1
Iran
1
Kazakhstan
1
Georgia
1
Vietnam
1
Uruguay
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
276
Clinical Guidelines
194
Women & Child Health
124
Public Health
78
Key Resources
28
Capacity Building
14
Pharmacy & Technologies
14
Toolboxes
Mental Health
198
COVID-19
159
TB
98
Caregiver
71
HIV
69
NCDs
54
AMR
41
NTDs
28
Planetary Health
27
Disability
20
Ebola
15
Refugee
14
Pharmacy
12
Rapid Response
11
Zika
9
Conflict
7
Cholera
6
Natural Hazards
6
Global Health Education
6
Polio
5
Social Ethics
5
Specific Hazards
2
Health Financing Toolbox
2
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
La hemorragia posparto (HPP) se define comúnmente como la pérdida de sangre
de 500 ml o más en el término de 24 horas después del parto. La HPP es la causa
principal de mortalidad materna en países de ingresos bajos y la causa primaria de
casi un cuarto de todas las defunciones maternas en ...
L’hémorragie du post-partum (HPP) est communément définie comme une perte
sanguine d’au moins 500 ml survenant dans les 24 heures qui suivent l’accouchement.
Elle est la première cause de mortalité maternelle dans les pays à revenu faible
et la cause principale de près d’un décès...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against...
BMC Health Services Research (2019) 19:458 https://doi.org/10.1186/s12913-019-4315-7
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiop...
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline
The recommendation in this document thus supersedes the previous WHO recommendation for the prevention of PPH as published in the 2012 guideline, WHO recommendations for the prevention and treatment of postpartum haemorrhage.
